Simcere Zaiming collaborates with TargetRx to introduce a third-generation ALK inhibitor ...Middle East

PR Newswire - News
NANJING, China, Sept. 2, 2024 /PRNewswire/ -- On September 02, 2024, Simcere Zaiming, an innovative oncology company under Simcere Pharmaceutical Group (2096.HK), announced a collaboration agreement with Shenzhen TargetRx Inc. The partnership focuses on the ALK/ROS1 dual receptor tyrosine...

Hence then, the article about simcere zaiming collaborates with targetrx to introduce a third generation alk inhibitor was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Simcere Zaiming collaborates with TargetRx to introduce a third-generation ALK inhibitor )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News